跳至主要内容
临床试验/NCT03731585
NCT03731585
进行中(未招募)
不适用

Online Psychosocial Intervention for Women With Lung Cancer Undergoing Treatment

M.D. Anderson Cancer Center1 个研究点 分布在 1 个国家目标入组 70 人2018年11月15日

概览

阶段
不适用
干预措施
Behavioral Intervention
疾病 / 适应症
Non-Small Cell Lung Carcinoma
发起方
M.D. Anderson Cancer Center
入组人数
70
试验地点
1
主要终点
BREATHE intervention in women with Lung Cancer determined successful by acceptability
状态
进行中(未招募)
最后更新
17天前

概览

简要总结

This trial studies how well online psychosocial intervention works in improving social well-being and support in women who are undergoing treatment for stage I-IV non-small cell lung cancer. Psychosocial intervention techniques, such as mindfulness, compassion, and emotional processing, may improve distress and help patients manage symptoms related to non-small cell lung cancer.

详细描述

PRIMARY OBJECTIVES: I. Examine the feasibility (primary outcome) of the BREATHE intervention in women with lung cancer (LC). SECONDARY OBJECTIVES: I. Establish the initial intervention efficacy regarding psychological distress (secondary outcome) and cancer symptoms (tertiary outcome) relative to an education comparison (EC) group. EXPLORATORY OBJECTIVES: I. Explore potential mediation (e.g., mindfulness, compassion, inflammatory processes) and moderation (e.g., demographic and medical factors) of the intervention effects. OUTLINE: Patients are randomized to 1 of 2 groups. GROUP I (PSYCHOLOGICAL): Patients participate in 5 psychological sessions and complete training on mindfulness, compassion, emotional processing, social support, generating positive emotions, and proactive coping strategies once a week for up to 5 weeks. Patients also complete questionnaires over 35 minutes and participate in video-based group sessions weekly for 5 weeks. GROUP II (EDUCATIONAL): Patients participate in 5 information sessions and receive education on lung cancer, symptom management, communication, and practicing self-care once a week for up to 5 weeks. Patients also complete questionnaires and participate in group sessions as in group I. After completion of study intervention, patients are followed up at 1 week and at 3 months.

注册库
clinicaltrials.gov
开始日期
2018年11月15日
结束日期
2027年9月30日
最后更新
17天前
研究类型
Interventional
研究设计
Parallel
性别
Female

研究者

责任方
Sponsor

入排标准

入选标准

  • Women diagnosed with stage I-IV non-small cell lung cancer within 3 months of diagnosis at the time of recruitment and receiving any type of treatment at the time of recruitment. For women with metastatic disease, disease must be stable (without disease progression based on patients' latest imaging impressions) per treating oncologist
  • Eastern Cooperative Oncology Group (ECOG) performance status of =\< 2
  • Have access to the internet
  • Able to read, write and speak English

排除标准

  • Major psychiatric or cognitive deficits that would impede the completion of self-report instruments as deemed by the clinical team
  • Regular (self-defined) participation in psychotherapy or a formal cancer support group

研究组 & 干预措施

Group I (psychological intervention)

Patients participate in 5 psychological sessions and complete training on mindfulness, compassion, emotional processing, social support, generating positive emotions, and proactive coping strategies once a week for up to 5 weeks. Patients also complete questionnaires over 35 minutes and participate in video-based group sessions weekly for 5 weeks.

干预措施: Behavioral Intervention

Group I (psychological intervention)

Patients participate in 5 psychological sessions and complete training on mindfulness, compassion, emotional processing, social support, generating positive emotions, and proactive coping strategies once a week for up to 5 weeks. Patients also complete questionnaires over 35 minutes and participate in video-based group sessions weekly for 5 weeks.

干预措施: Questionnaire Administration

Group I (psychological intervention)

Patients participate in 5 psychological sessions and complete training on mindfulness, compassion, emotional processing, social support, generating positive emotions, and proactive coping strategies once a week for up to 5 weeks. Patients also complete questionnaires over 35 minutes and participate in video-based group sessions weekly for 5 weeks.

干预措施: Support Group Therapy

Group II (educational intervention)

Patients participate in 5 information sessions and receive education on lung cancer, symptom management, communication, and practicing self-care once a week for up to 5 weeks. Patients also complete questionnaires and participate in group sessions as in group I.

干预措施: Educational Intervention

Group II (educational intervention)

Patients participate in 5 information sessions and receive education on lung cancer, symptom management, communication, and practicing self-care once a week for up to 5 weeks. Patients also complete questionnaires and participate in group sessions as in group I.

干预措施: Questionnaire Administration

Group II (educational intervention)

Patients participate in 5 information sessions and receive education on lung cancer, symptom management, communication, and practicing self-care once a week for up to 5 weeks. Patients also complete questionnaires and participate in group sessions as in group I.

干预措施: Support Group Therapy

结局指标

主要结局

BREATHE intervention in women with Lung Cancer determined successful by acceptability

时间窗: Up to 3 months

Acceptability assessed by ≥ 75% of participants indicating that the program is useful and enjoyable in each arm.

BREATHE intervention in women with Lung Cancer determined successful by overall accrual

时间窗: Up to 3 months

Overall accrual assessed by ≥ 50% of eligible patients consent (i.e., approach 140 to achieve 70 that consent).

BREATHE intervention in women with Lung Cancer determined successful by attrition

时间窗: Up to 3 months

Attrition assessed by ≥ 71% of enrolled patients (≥ 50 patients) complete T1 and T2 assessments;

BREATHE intervention in women with Lung Cancer determined successful by adherence

时间窗: Up to 3 months

Adherence assessed by ≥ 75% of all practice sessions are attended in each arm.

次要结局

  • Efficacy regarding psychological distress: CES-D(Up to 3 months)
  • Efficacy regarding cancer symptoms: IES(Up to 3 months)

研究点 (1)

Loading locations...

相似试验